Wang Wesley W, Singha Roy Soumya Jyoti, Parker Christopher G
Department of Chemistry, The Scripps Research Institute, La Jolla, California 92037, United States.
Acc Chem Res. 2025 Sep 2;58(17):2695-2707. doi: 10.1021/acs.accounts.5c00326. Epub 2025 Aug 13.
ConspectusProtein acetylation is a pervasive and reversible post-translational modification (PTM) that impacts various protein features including stability, localization, and interactions and regulates diverse cellular functions, including transcription, signal transduction, and metabolism. This process is orchestrated by "writer" lysine acetyltransferases (KATs) and "eraser" deacetylases (KDACs), and its dysregulation is implicated in a broad spectrum of diseases including cancer, metabolic syndromes, and immune disorders. However, dissecting the roles of specific acetylation events in live cells remains a challenge due to the lack of tools that enable precise, rapid, and reversible acetylation at defined protein sites.To begin addressing these challenges, we recently developed AceTAG (acetylation tagging), a chemically induced proximity (CIP) platform for targeted protein acetylation in live cells. AceTAG molecules are heterobifunctional ligands that recruit endogenous KATs─such as p300/CBP or PCAF/GCN5─to a tagged protein of interest, enabling selective, tunable, and dynamic acetylation. We demonstrated the utility of AceTAG across diverse proteins, including histone H3.3, p65/RelA, and p53. We further show that chemically induced acetylation of p53, including multiple hotspot p53 mutants, leads to enhanced stability and transcriptional activation, underscoring the potential of AceTAG for functional investigations and the potential for therapeutic exploration.In this Account, we provide an overview of protein acetylation and survey chemical biology technologies for its manipulation, with a focus on AceTAG. We describe the conceptual motivation of AceTAG, applications, technical considerations, and recent efforts to expand this concept to endogenous proteins. Finally, we offer a forward-looking perspective of targeted acetylation as a chemical tool to investigate the biology of this PTM, as well as its potential as a therapeutic modality.
概述
蛋白质乙酰化是一种普遍存在且可逆的翻译后修饰(PTM),它会影响各种蛋白质特性,包括稳定性、定位和相互作用,并调节多种细胞功能,包括转录、信号转导和代谢。这个过程由“书写者”赖氨酸乙酰转移酶(KATs)和“擦除者”去乙酰化酶(KDACs)精心调控,其失调与包括癌症、代谢综合征和免疫紊乱在内的多种疾病有关。然而,由于缺乏能够在特定蛋白质位点实现精确、快速和可逆乙酰化的工具,剖析活细胞中特定乙酰化事件的作用仍然是一项挑战。
为了开始应对这些挑战,我们最近开发了AceTAG(乙酰化标记),这是一种用于活细胞中靶向蛋白质乙酰化的化学诱导邻近(CIP)平台。AceTAG分子是异双功能配体,可将内源性KATs(如p300/CBP或PCAF/GCN5)招募到感兴趣的标记蛋白质上,从而实现选择性、可调谐和动态乙酰化。我们展示了AceTAG在多种蛋白质中的实用性,包括组蛋白H3.3、p65/RelA和p53。我们进一步表明,对p53进行化学诱导的乙酰化,包括多个热点p53突变体,会导致稳定性增强和转录激活,这突出了AceTAG在功能研究方面的潜力以及治疗探索的潜力。
在本综述中,我们概述了蛋白质乙酰化,并综述了用于其操纵的化学生物学技术,重点是AceTAG。我们描述了AceTAG的概念动机、应用、技术考虑因素以及最近将这一概念扩展到内源性蛋白质的努力。最后,我们前瞻性地展望了靶向乙酰化作为一种化学工具来研究这种PTM的生物学特性,以及其作为一种治疗方式的潜力。